EMSAM is a Transdermal Patch in the Human Prescription Drug category. It is labeled and distributed by Mylan Specialty L.p.. The primary component is Selegiline.
| Product ID | 49502-902_17e3a168-596b-4441-9c2a-8eac4c814808 |
| NDC | 49502-902 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EMSAM |
| Generic Name | Selegiline |
| Dosage Form | Patch |
| Route of Administration | TRANSDERMAL |
| Marketing Start Date | 2006-02-27 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021336 |
| Labeler Name | Mylan Specialty L.P. |
| Substance Name | SELEGILINE |
| Active Ingredient Strength | 12 mg/24h |
| Pharm Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2006-02-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021336 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-02-27 |
| Marketing Category | NDA |
| Application Number | NDA021336 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-02-27 |
| Ingredient | Strength |
|---|---|
| SELEGILINE | 12 mg/24h |
| SPL SET ID: | b891bd9f-fdb8-4862-89c5-ecdd700398a3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49502-900 | EMSAM | selegiline |
| 49502-901 | EMSAM | selegiline |
| 49502-902 | EMSAM | selegiline |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EMSAM 78672729 3243020 Dead/Cancelled |
Somerset Pharmaceuticals, Inc. 2005-07-18 |
![]() EMSAM 78672684 not registered Dead/Abandoned |
Somerset Pharmaceuticals, Inc. 2005-07-18 |
![]() EMSAM 76053545 2897561 Live/Registered |
Somerset Pharmaceuticals, Inc. 2000-05-22 |